Essential thrombocythemia: Diagnosis and treatment, with special emphasis on the use of anagrelide

Hematology

Volumn 7, Issue 3, 2002, Pages 173-177

  Andersson, Borje S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; ANAGRELIDE; ANTITHROMBOCYTIC AGENT; HYDROXYUREA; PHOSPHORUS 32; RECOMBINANT ALPHA INTERFERON; ANTINEOPLASTIC AGENT; QUINAZOLINE DERIVATIVE;

ACUTE GRANULOCYTIC LEUKEMIA; ALGORITHM; ARTICLE; BLEEDING; CARDIOTOXICITY; CONTROLLED STUDY; DNA ALKYLATION; DRUG INDICATION; DRUG SPECIFICITY; GASTROINTESTINAL TOXICITY; HEADACHE; HEMOLYTIC ANEMIA; HUMAN; HYPOTHYROIDISM; MALIGNANT NEOPLASTIC DISEASE; MYELODYSPLASTIC SYNDROME; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; TERATOGENICITY; THROMBOCYTHEMIA; THROMBOCYTOPHERESIS; DRUG CONTRAINDICATION; DRUG EFFECT; REVIEW; THROMBOCYTE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; HUMANS; PLATELET AGGREGATION INHIBITORS; QUINAZOLINES; THROMBOCYTHEMIA, HEMORRHAGIC; TREATMENT OUTCOME;

EID: 0036398450     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/10245330290028597     Document Type: Article

References (19)

1. Murphy, S., Iland, H., Rosenthal, D. and Lazlo, J. (1986) "Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group", Semin. Hematol. 23, 177.
2. Pearson, T.C. (1991) "Primary thrombocythemia: diagnosis and management", Br. J. Haematol. 78, 145.
3. Van Genderen, P.J.J. and Michiels, J.J. (1993) "Primary thrombocythaemia, diagnosis, clinical manifestations and management", Ann. Hematol. 67, 57.
4. Singal, U., Prasad, A.S., Halton, D.M. and Bishop, C. (1983) "Essential thrombocythemia: a clonal disorder of the hematopoietic stem cell", Am. J. Hematol. 14, 193.
5. El-Kassar, N., Hetet, G., Briere, J. and Grandchamp, B. (1997) "Clonality analysis of hematopoiesis in essential thrombocythaemia, advantages of studying T lymphocytes and platelets", Blood 89, 28.
6. Anger, B., Janssen, J.W.G., Schrezenmeier, H., Hehlmann, R., Heimpel, H. and Bartram, C.R. (1990) "Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms", Leukemia 4, 258.
7. Murphy, S., Peterson, P., Iland, H. and Lazlo, J. (1997) "Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival and leukemic transition by treatment", Semin. Hematol. 34, 29.
8. Hoffman, R. (2000) "Primary Thrombocythemia", In: Hoffman, R., Benz, E., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E. and McGlave, P., eds, Hematology, Basic Principles and Practice, 3rd Ed. (Churchill Livingstone, Philadelphia PA).
9. Balduini, C.L. (1992) "Primary thrombocythemia: new drugs for an evolving disease", Haemostasis 77, 297.
10. Frenkel, E.P. (1991) "Southwestern Internal Medicine Conference: The clinical spectrum of thrombocytosis and thrombocythemia", Am. J. Med. Sci. 301, 69.
11. Van Genderen, P.J.J., Mulder, P.G.H., Waleboer, M., van de Moesdijk, D. and Michiels, J.J. (1997) "Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin", Br. J. Haematol. 97, 179.
12. Lengfelder, E., Griesshammer, M. and Hehlmann, R. (1996) "Interferon-alpha in treatment of essential thrombocythemia", Leuk. Lymphoma 22, 135.
13. Talpaz, M., Kurzrock, R., Kantarjian, H., O'Brien, S. and Gutterman, J.U. (1989) "Recombinant interferon-alpha therapy of Philadelphia chromosome negative myeloproliferative disorders with thrombocytosis", Am. J. Med. 86, 554.
14. Tefferi, A., Elliot, M.A., Solberg, Jr., L.H. and Silverstein, M.N. (1997) "New drugs in essential thrombocythemia and polycythemia vera", Blood Rev. 11, 1.
15. Silverstein, M.N., Solberg, L.A., Silver, R.T., Fitch, T., Mazur, E., Allen, S., Cuttner, J., Frenkel, G., Cherng, N.C., Yovan, N., Grechko, J., Pettit, R.M., Rosenbloom, B., Knospe, W., Colon-Otero, G., Doyle, G., Gilbert, H.S., Weick, J., Miller, W., Burroughs, J., Khoory, M. and Schacter, L.P. (1992) "Anagrelide, a therapy for thrombocythemic states: experience in 577 patients", Am. J. Med. 92, 69.
16. Tefferi, A., Silverstein, M.N., Pettit, R.M., Mesa, R.A. and Solberg, Jr., L.A. (1997) "Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of action, efficacy, toxicity, current indications", Semin. Thromb. Hemost. 23, 379.
17. Oertel, M.D. (1998) "Anagrelide, a selective thrombocytopenic agent", Am. J. Health-System Pharm. 55, 1979.
18. Mazur, E.M., Rosmarin, A.G., Sohl, P.A., Newton, J.L. and Narendan, A. (1992) "Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans", Blood 79, 1931.
19. Laguna, M.S., Kornblihtt, L.I., Marta, R.F., Michiels, J.J. and Molinas, F.C. (2000) "Effectiveness of anagrelide in the treatment of symptomatic patients with essential thrombocythemia", Clin. Appl. Thromb. Hemost. 6, 157.